ABYRX INC

ABYRX INC specializes in advanced manufacturing and precision engineering services aligned with NAICS 339113, which encompasses medical equipment and supplies manufacturing. The company delivers high-precision component fabrication, assembly, and quality assurance for mission-critical healthcare and defense applications, leveraging lean manufacturing principles and ISO-compliant production workflows. Their technical expertise includes CNC machining, cleanroom assembly, regulatory documentation support, and validation protocols required for FDA-regulated environments. ABYRX differentiates itself through rigorous process control, traceability systems, and a focus on low-volume, high-complexity production runs that demand stringent tolerances and material integrity. No agency-specific award history is available to characterize direct government partnerships or programmatic engagements. Consequently, there is insufficient data to identify recurring relationships with federal departments or the nature of work performed for specific clients. The company’s primary industry focus is medical device manufacturing, where they support the development and production of diagnostic, therapeutic, and implantable devices requiring FDA 21 CFR Part 820 compliance. Their market positioning centers on niche, high-reliability manufacturing for regulated sectors, particularly where design control, biocompatibility testing, and sterile packaging are essential. They operate within the broader biomedical engineering supply chain, serving OEMs and contract developers requiring certified production capabilities. ABYRX INC is structured as a small business under the 2L entity classification and is headquartered in Stamford, Connecticut. The company holds no active government certifications, including 8(a), HUBZone, or WOSB status. Their geographic footprint is localized to the Northeast, with operations centered on precision manufacturing infrastructure. While their government market presence is not yet documented through public awards, their technical capabilities align with federal procurement needs in medical technology and advanced industrial production.